Table 3 Association between the choice of local modality treatment and specified patient characteristics
Number of patients (percentage), excluding missing data | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
CCLG | GPOH | |||||||||
N | None | RT alone | Surgery alone | RT and surgery | N | None | RT alone | Surgery alone | RT and surgery | |
Disease | ||||||||||
Localised | 150 | 9 (6) | 53 (35) | 59 (39) | 29 (19) | 315 | 3 (1) | 55 (17) | 63 (20) | 194 (62) |
Metastatic | 56 | 9 (16) | 27 (48) | 11 (20) | 9 (16) | 101 | 4 (4) | 30 (30) | 8 (8) | 59 (58) |
Localised extremity disease | 91 | 5 (5) | 18 (20) | 46 (50) | 22 (24) | 155 | 1 (1) | 8 (5) | 44 (28) | 102 (66) |
Localised pelvic disease | 31 | 0 | 24 (77) | 6 (19) | 1 (3) | 79 | 1 (1) | 27 (36) | 7 (9) | 39 (53) |
Primary site | ||||||||||
Central axis | 84 | 9 (11) | 52 (62) | 14 (17) | 9 (11) | 226 | 4 (2) | 73 (32) | 22 (10) | 127 (56) |
Extremity | 115 | 7 (6) | 28 (24) | 54 (47) | 26 (23) | 189 | 3 (2) | 11 (6) | 48 (25) | 127 (67) |
Volume (ml) | ||||||||||
< 100 | 57 | 5 (9) | 19 (33) | 27 (47) | 6 (10) | 111 | 3 (3) | 26 (23) | 16 (14) | 66 (59) |
≥ 100 | 146 | 13 (9) | 61 (42) | 40 (27) | 32 (22) | 292 | 4 (1) | 54 (18) | 52 (18) | 182 (62) |
Age (years) | ||||||||||
0–9 | 34 | 0 | 10 (29) | 22 (65) | 2 (6) | 92 | 1 (1) | 18 (20) | 22 (24) | 51 (55) |
10–14 | 74 | 5 (7) | 32 (43) | 24 (32) | 13 (18) | 118 | 0 | 30 (25) | 11 (9) | 77 (65) |
15–19 | 56 | 5 (9) | 25 (45) | 13 (23) | 13 (23) | 111 | 3 (3) | 21 (19) | 21 (19) | 66 (59) |
20–35 | 43 | 8 (19) | 14 (33) | 11 (26) | 10 (23) | 97 | 3 (3) | 16 (16) | 17 (18) | 61 (63) |